SITC (Society for Immunotherapy of Cancer) - 2020 ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1667 of 1720  at  10/27/2020 4:01:39 PM  by

auh2oman


SITC (Society for Immunotherapy of Cancer) - 2020 ...

This meeting is scheduled to take place virtually online from November 10 -15. The following is a pre-conference program pertaining to Immunotherapy Resistance and Failure that is on November 9th:
 
 
Session I: Defining Immune Checkpoint Inhibitor Resistance
9:05 a.m.Definitions of Resistance and Gaps in Current Understanding
Ryan J. Sullivan, MD -
Massachusetts General Hospital
9:35 a.m.

Mechanisms of Resistance and Possible New Combinations for Overcoming Them
Paolo A. Ascierto, MD - Istituto Nazionale Tumori IRCCS Fondazione Pascale

9:55 a.m.Immunotherapy Primary and Acquired Resistance
Antoni Ribas, MD, PhD - University of California Los Angeles

 
Dr. Paolo A.  Ascierto, MD is the Principal Investigator for Idera's Illuminate - 301 Phase lll trial in Napoli, Italy.
 
 
 
https://www.sitcancer.org/2020/program/pre-conference-programs/immunotherapyresistance
 
 
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...